Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125310553 | 12531055 | 3 | F | 2016 | 20160922 | 20160706 | 20160926 | EXP | US-009507513-1606USA011726 | MERCK | 61.63 | YR | F | Y | 73.47000 | KG | 20160926 | CN | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125310553 | 12531055 | 1 | PS | ZOCOR | SIMVASTATIN | 1 | Oral | 10 MG, QD | 680 | MG | Y | 19766 | 10 | MG | TABLET | QD | |||
| 125310553 | 12531055 | 2 | SS | ZOCOR | SIMVASTATIN | 1 | Oral | 5 MG, QD | 680 | MG | Y | 19766 | 5 | MG | TABLET | QD | |||
| 125310553 | 12531055 | 3 | SS | ZOCOR | SIMVASTATIN | 1 | Oral | 20 MG, QD | 680 | MG | Y | 19766 | 20 | MG | TABLET | QD | |||
| 125310553 | 12531055 | 4 | SS | SIROLIMUS. | SIROLIMUS | 1 | Oral | 1 PILL ONCE DAILY | U | 0 | 1 | DF | QD | ||||||
| 125310553 | 12531055 | 5 | SS | SIROLIMUS. | SIROLIMUS | 1 | 0.5 MG, UNK | U | 0 | .5 | MG | ||||||||
| 125310553 | 12531055 | 6 | SS | CRESTOR | ROSUVASTATIN CALCIUM | 1 | D | 0 | |||||||||||
| 125310553 | 12531055 | 7 | C | PRINIVIL | LISINOPRIL | 1 | Oral | 10 MG, QD, FOR YEARS | 0 | 10 | MG | TABLET | QD | ||||||
| 125310553 | 12531055 | 8 | C | PRINIVIL | LISINOPRIL | 1 | Oral | 20 MG, QD, FOR YEARS | 0 | 20 | MG | TABLET | QD | ||||||
| 125310553 | 12531055 | 9 | C | PRILOSEC | OMEPRAZOLE MAGNESIUM | 1 | Oral | 20 MG, QD, FOR YEARS | 0 | 20 | MG | CAPSULE | QD | ||||||
| 125310553 | 12531055 | 10 | C | TIMOLOL MALEATE. | TIMOLOL MALEATE | 1 | Ophthalmic | 0.5 MG, QD | 0 | .5 | MG | EYE DROPS, SOLUTION | QD | ||||||
| 125310553 | 12531055 | 11 | C | VITAMINS (UNSPECIFIED) | VITAMINS | 1 | FOR YEARS | 0 | |||||||||||
| 125310553 | 12531055 | 12 | C | ASPIRIN. | ASPIRIN | 1 | LOW DOSE, FOR YEARS | 0 | TABLET |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 125310553 | 12531055 | 1 | Blood cholesterol increased |
| 125310553 | 12531055 | 2 | Lymphangioleiomyomatosis |
| 125310553 | 12531055 | 4 | Lymphangioleiomyomatosis |
| 125310553 | 12531055 | 6 | Blood cholesterol increased |
| 125310553 | 12531055 | 7 | Blood pressure increased |
| 125310553 | 12531055 | 9 | Gastrooesophageal reflux disease |
| 125310553 | 12531055 | 10 | Glaucoma |
| 125310553 | 12531055 | 11 | Routine health maintenance |
| 125310553 | 12531055 | 12 | Routine health maintenance |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 125310553 | 12531055 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 125310553 | 12531055 | Abdominal pain | |
| 125310553 | 12531055 | Aphthous ulcer | |
| 125310553 | 12531055 | Asthenia | |
| 125310553 | 12531055 | Conjunctivitis | |
| 125310553 | 12531055 | Diarrhoea | |
| 125310553 | 12531055 | Drug ineffective | |
| 125310553 | 12531055 | Gingivitis | |
| 125310553 | 12531055 | Headache | |
| 125310553 | 12531055 | Malaise | |
| 125310553 | 12531055 | Product use issue | |
| 125310553 | 12531055 | Pulmonary function test abnormal | |
| 125310553 | 12531055 | Upper respiratory tract infection |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 125310553 | 12531055 | 1 | 201502 | 0 | ||
| 125310553 | 12531055 | 3 | 20160526 | 20160701 | 0 | |
| 125310553 | 12531055 | 4 | 201302 | 0 | ||
| 125310553 | 12531055 | 10 | 2011 | 0 |